Uniqure NV
Ownership
Ownership Structure
Who owns Uniqure NV (QURE)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 82.9% of the shares are freely tradable; institutional investors hold 84.9%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| venBio Select Advisor LLC | 8.59 | 5,959,595 | -3.1 | 03/31/2026 |
| Aberdeen Group PLC | 4.11 | 2,848,117 | -46.3 | 06/30/2026 |
| JPMorgan Chase & Co | 4.09 | 2,837,466 | -3.3 | 03/31/2026 |
| RTW INVESTMENTS, LLC | 3.73 | 2,586,356 | -30.3 | 03/31/2026 |
| State Street Corp | 3.26 | 2,260,512 | -30.0 | 03/31/2026 |
| Orbimed Advisors LLC | 3.08 | 2,136,149 | +189.7 | 03/31/2026 |
| FMR Inc | 2.51 | 1,743,808 | -72.1 | 03/31/2026 |
| BlackRock Inc | 2.50 | 1,733,458 | -12.2 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| State Street® SPDR® S&P® Biotech ETF | 3.64 | 2,524,656 | -1.1 | 08/31/2026 |
| JPMorgan Growth Advantage A | 2.55 | 1,771,632 | +43.1 | 07/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.